Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06253195
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-02-02
Brief Title:
BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HRHER2- Breast Cancer and Other Advanced Solid Tumors
Sponsor:
BeiGene
Organization:
BeiGene
Conditions & Keywords Data
Conditions:
| Name |
|---|
| HER2-negative Breast Cancer |
| Advanced Solid Tumor |
| Metastatic Solid Tumor |
| Hormone-receptor-positive Breast Cancer |
| Breast Cancer |
| Metastatic Breast Cancer |
| Hormone Receptor Positive Malignant Neoplasm of Breast |